Ultragenyx Pharmaceutical Inc. buy Robert W. Baird
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€39.91
Performance (%)
23.71%
Price
09:46
?
Summary
This prediction is currently active. The BUY prediction by Robert_W__Baird currently has a performance of 23.71%. This prediction currently runs until 30.12.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -3.313% | -3.313% |
| iShares Core DAX® | 0.411% | 8.821% |
| iShares Nasdaq 100 | 3.678% | 10.820% |
| iShares Nikkei 225® | 2.701% | 15.247% |
| iShares S&P 500 | 2.445% | 7.933% |
Comments by Robert_W__Baird for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Robert W. Baird from $72.00 to $47.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.00
31.05.24
31.05.24
€66.15
31.05.25
31.05.25
-17.78%
01.06.25
01.06.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.80
30.01.24
30.01.24
€62.74
30.01.25
30.01.25
1.96%
31.01.25
31.01.25